SB1 Pharma offers a new, patented approach to identify and treat cancer tumours that primarily affect children.
Treats cancer tumours affecting children.
Portfolio company since 2019.
Portfolio Manager LU Holding:
christine [dot] widstrand [at] innovation [dot] lu [dot] se (Christine Widstrand), phone +46 70 928 63 78